Useful Drugs Definitely not Cost With the Small Profits Purchaser

There have been many new biological drugs approved by the FDA to deal with psoriasis since 2003 as one example of an inflated drug price that many lower income people can’t get access to because Medicaid and Medicare won’t pay for them because of the skyrocketing prices. The new blood thinner “Eliquis” is paid for by Medicaid and Medicare at $200 a bottle. The COPD inhalers which are fairly new will also be paid for by the government without hesitation in the region of $150 a pop. Some states pay for the very expensive $400 and above hearing aids and some don’t. Why aren’t the new biological drugs that came out to deal with psoriasis since 2003 paid for by the government?

I guess this is one moment where I’m going to answer the question I simply asked of the articles readers. In the above linked article I posted to go with this specific article mcdougal states these biological drugs to deal with psoriasis will NOT be open to folks who are on Medicaid and Medicare because of price. All the drug companies who’ve created their very own biological psoriasis treatments have pushed people on Medicaid and Medicare away from receiving treatment with these drugs through the high cost of the drugs. Medicare Part D prescription drug plan will probably pay the bulk cost of “biological’s” but the co pay is between $1200 and $5000 which still keeps individuals from having the biological’s.

The spin is some of these biological drug companies have programs to produce the drugs free to low income patients who’ve private insurance only. Drug companies have stated in several articles I’ve read when the patients have Medicare or Medicaid they will NOT be eligible for the free programs.

Quote From The cheapest GoodRx price for the most frequent version of Humira is around $5,130.76, 38% off the typical retail price of $8,309.04.

These biological psoriasis treatments aren’t life saving so Medicare and Medicaid do not recognize the inflated cost by drug companies as a required expense. The drug companies know this and are interested this way. Back in 2003 when these biological psoriasis treatments were entering the drug marketplace they certainly were affordable and insurance companies acquired the expense if a reasonable deductible was paid. After 2012 the insurance companies started to get rid of individuals with psoriasis because the payouts on the biological treatments were going up and getting extremely expensive.
The “Epipen Injector” used to deal with heroin overdoses was attacked viciously by the U.S. government when the owner of the organization jacked up the price so high only the truly wealthy could afford them. Medicaid and Medicare in certain states do cover generic Epipen’s but reject brand names. I’ve arrive at my conclusion about why this and other high drug prices are happening that keep some of these drugs out of the reach of numerous folks who are on Medicare and Medicaid.

Come ON! of course it’s collusion involving the “Big Pharma” drug industry and members of congress. But once the collusion deals lose their freshness it’s the drug industry that is forced to take the fall.

When these scams to achieve personal wealth arrive at light as in the opioid epidemic that is ongoing now where billions of dollars are increasingly being paid out by the drug companies to the states our congressional representatives who profited from opioids though insider trading investments walk around with no possibility of repercussion for their involvement in the scheme.

If you look at Canada which is a country where government has to cover ALL healthcare costs you will see the lowest prices on quality drugs anywhere because the government forces prices down to reduce government expenditures. All the drug companies that put together high profit drug plans to fill their pockets are destroyed without question by the Canadian government. In the U.S. our congressional representatives steer thought away from destroying excessive profit taking by the drug companies because they’re committed to these drug companies for their very own personal profit. Congressional Representatives enter congress with meager wealth and leave with excessive riches.

I simply bet ya if a person gained use of the investments of our congressional leaders they’d find many cases of drug company investments who’ve very high drug prices on popular needed drugs that really work to enhance a persons health. Congress voted to give drug companies a 20 year patent before generics might be produced with a 5 year extension if certain conditions are met comprehending that high drug prices would develop giving congressional insiders great profit making investment opportunities.

I hear now and again on news shows the patent time is now 12 years but I haven’t seen this 12 year patent time period in “Wikipedia” or anywhere else. buy codeine online All I see are 20 year patent time frames. I searched around and found out after the drug is invented and a patent applied it may take around 8 years to get FDA approved which leaves 12 years for the drugs to stay on a patent.

Which of our congressional representatives would vote against this time honored tradition of screwing U.S. Citizens in the behind by increasing patent times so they could increase their very own personal cash value through outrageous drug prices?

So lets take the biological psoriasis drugs for instance since they have only been around since 2003 or so. “Humira” was the initial biological patent approved by the FDA for the treatment of Rheumatoid Arthritis. Down the road “Humira” was approved for the treatments of various other medical conditions including psoriasis.

If there is a 20 year patent on these drugs then “Humira” is going to be priced out of reach of most people until 2023 which was a huge profit taking window for congressional representatives. “Skyrizi” which will be new this season in 2019 is priced around “$15,000” for a one year kit which will be 5 or 6 shots. “Humira” is injection and pill form. “Skyrizi” eliminates 90% of psoriasis with the initial two shots which are 4 weeks apart. “Skyrizi” will remain priced quite high until about 2039 when it features a 20 year patent.

When Humira comes from patent in 2023 it will send the manufacturing of it to the generic drug companies and drop the price to promote value that might mean everyone on Medicaid and Medicare could have an opportunity to be treated with it. All biological drug manufacturers will have to drop their prices and to a fair level because ALL doctors will direct their patents to Humira leaving other drug companies with something that cannot be sold because of price. In “India” a common kind of “Humira” is being manufactured and the monthly cost is only $400 which will be only down a couple of hundred from the discounted prices in the U.S.. After “Humira” goes off patent in the U.S. even the generic “India” brand will fall in price even further.

I read it might cost a drug company over a billion dollars to develop a drug but this is “Bull Hicky” ;.For one think a drug company isn’t a drug company without a team of researchers. In reality a drug company is only researchers. A drug company after it starts creating a make money from the drugs they produced in the initial place must budget for a permanent research team to create future drug profits. The investigation team gets its paychecks from previous released drug sales always and forever and NO recouping of costs for the development of a fresh drug is ever needed. A drug company is just a huge laboratory high in scientists that receives a commission regularly to create new drugs and do constant experiments. No extra financial outputs are going on to drive drug prices through the roof.

Popular new releases of drugs are only total profit magnets for drug companies and congressional representatives. It’s like the town or city you reside for making you believe that the price to deal with an issue will exceed the taxes already collected to cover the staff and resources to deal with the problems that are actually funded.

The “Stock Act” was enacted on April 4th, 2012 which required every member of congress to create their investment transactions on the websites within 45 days of earning them for public viewing. Congressional representatives do not want their investments looked over nevertheless when public demand dictated that it become law to have their investments made public they had to give into the general public demand and folded to it. Following a year congress went against public demand on April 15th 2013 and voted to kill the parts of the law that will make their investments public. Congress couldn’t fulfill themselves at the trouble of U.S. Citizens with riches galore through insider trading which they think they have a right to accomplish since there’s no legal entity which will punish them.

As Effective Drug Markets Grow Any Drugs Under Patents Sore In Price To The Point Only The Wealthy Can Afford Them. In 2012 The Drug Companies Decided Psoriasis Biological’s Were A Profit Maker In A Fast Growing Market. The Move Was Made To Raise The Prices So Extreme Profits Could Be Realized Through There Patent Monopoly Scheme Of Marketing To The Rich

Biological psoriasis drugs were priced reduced in 2012 and insurance companies paid for them if an affordable deductible was paid by someone who had a great job. After the marketplace for biological,s started to grow the marketplace became hijacked by the wealthy as a means to boost their personal values by increasing the costs and marketing these drugs to the wealthy and themselves that are the wealthy for massive profit taking. People have been getting their psoriasis drugs paid for through their insurance companies were being dropped off their insurance plans. Although insurance carriers paid for biological’s before 2012 low income Medicaid and Medicare patients still did not have use of these drugs. Medicare Part D prescription plan pays the bulk of cost but the copay is $1200 to $5000 dollars meaning most Medicare patients do not have use of biological’s.

There’s no other way you can look at it. “Epipen’s” were getting the same treatment, they certainly were introduced at a lowered price then hijacked on the market only to the wealthy which would produce high profits with decreased production costs. I keep running to the hearing aid problems that were suppose to have been priced to the thousands of dollars then being reduced to under $700 which will be still to expensive and an arena of massive profit taking. Advanced computer parts are cheaper than hearing aids?

With your drug companies as has been any business who holds a monopoly on any needed or popular product through government mandate the higher prices only the wealthy can pay are dictated meaning less production is going to be needed that means lower production costs and the same or maybe more profit levels are kept. Production at market demand means higher manufacturing costs with lower profit margins.

Leave a Reply

Your email address will not be published. Required fields are marked *